Imitation biologics are therapeutically equivalent to the original drugs
Monday, October 19, 2015 - 12:00
in Health & Medicine
Rheumatologists have been analyzing clinical data on biosimilars that have already been approved for use. The term 'biosimilars' refers to drugs that mimic the effects of biologics. A particular focus of the article is the efficacy of biosimilars that have already been approved for the treatment of rheumatic diseases within the past three years.